LORI RHINE: Open Payments
NPI 1588823322 · BELLEVILLE, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$306 in 17 payments from 10 companies in 2025. Trend: 2023 $306 · 2024 $526 · 2025 $306
Food & beverage: $306
| Company | Payments | Amount |
|---|---|---|
| Paratek Pharmaceuticals, Inc. | 6 | $103 |
| Otsuka America Pharmaceutical, Inc. | 2 | $44 |
| Xeris Pharmaceuticals, Inc. | 2 | $38 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $21 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $19 |
| Corcept Therapeutics | 1 | $17 |
| Novo Nordisk Inc | 1 | $17 |
| Tonix Medicines, Inc. | 1 | $17 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $16 |
| Amgen Inc. | 1 | $14 |
Products named: NUZYRA, REXULTI, KEVEYIS, Kerendia, CAPLYTA, Korlym, TONMYA, XIFAXAN.
Industry payments across KS — which companies pay providers there.
